CBAT
CBAK EnergyDAI scenario view
RankAlpha Sentiment CodexPost-earnings T+3AI sentiment snapshot
AI commentary
As of May 9, 2026, the primary company sources checked showed the latest earnings materials on March 30, 2026 and the latest SEC event filing on May 1, 2026; I did not confirm a new company earnings filing on the scheduled May 7, 2026 follow-up date, so this remains a monitoring update rather than a fresh post-print thesis reset. The anchor price of $0.7852 on May 7, 2026 is below $1 and consistent with the renewed Nasdaq deficiency overhang. Coverage is thin, with at least one sponsored small-cap note but no broad analyst-revision set confirmed, so confidence should stay modest.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
CBAK's FY2025 filing and March 30, 2026 earnings materials showed revenue rose to $195.2M, with LEV revenue up 252% and Hitrans up 123%, but gross margin fell to 9.4% and net loss attributable to shareholders was $9.4M as new-line ramp costs and inventory write-downs weighed on results [#10-K-2026-03-31].
The 10-K says the new 40135 line has 2.3 GWh designed capacity with a robust order book, Dalian capacity is projected to reach 3.3 GWh by early 2027, Nanjing Phase I and II total 4.5 GWh, and a new 10,000-metric-ton cathode plant is slated for September 2026 completion with full operation expected in 1H 2027 [#10-K-2026-03-31].
On April 30, 2026 the company received a Nasdaq notice for failing the $1.00 minimum bid requirement after 30 consecutive business days below $1, with a compliance deadline of October 27, 2026; this is a direct near-term sentiment and liquidity risk [#8-K-2026-05-01].
Recommendation
No formal recommendation provided.

